Boston, MANCT05327465Now EnrollingIRB Ready

Androgen Deprivation Therapy Clinical Trial in Boston, MA

Access cutting-edge androgen deprivation therapy treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Dana-Farber Cancer Institute

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access androgen deprivation therapy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related androgen deprivation therapy treatment provided free

Apply for This Boston Location

Check if you qualify for this androgen deprivation therapy clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Androgen Deprivation Therapy Study in Boston

The purpose of this research is to determine whether a 16-week culturally tailored, technology-based, aerobic and resistance exercise intervention improves cardiovascular risk factors in Black men diagnosed with prostate cancer and are undergoing androgen deprivation therapy (ADT), and whether it will also improve physical fitness and function, body composition, and outcomes such as quality of life, cancer symptoms, and self-esteem. Participants in this study will be randomly assigned to one of two groups: 1) Aerobic and resistance exercise, or 2) Usual care.

Sponsor: Dana-Farber Cancer Institute

Who Can Participate

Inclusion Criteria

Patients must meet all criteria to be eligible, including travel to Dana-Farber Cancer Institute (DFCI) to collect research data to address the study question.
Over 18 years old; children under the age of 18 will be excluded due to the rarity of the disease
Histologically diagnosed of localized or metastatic prostate cancer
Have been receiving androgen deprivation therapy (ADT) (i.e., luteinizing hormone-releasing hormone \[LHRH\] agonist/antagonist and/or androgen receptor \[AR\] agonist/antagonist) for at least one month with a plan to continue ADT for at least 4 months at the time of recruitment
Self-identify as Black
Medically cleared to participate in exercise by their referred physician or a certified clinical exercise physiologist
Are without medical conditions that could exacerbate with exercise, such as bone disease (excluding bone metastases) at imminent risk of fracture or uncontrolled cardiopulmonary or metabolic diseases
Speak English and/or Spanish
Currently participate in less than or equal to 60 minutes of moderate or vigorous structured exercise/week
Willing to travel to DFCI for necessary data collection
Ability to communicate and complete written forms in English and/or Spanish

Exclusion Criteria

Are not receiving ADT (i.e., LHRH agonist/antagonist and/or AR agonist/antagonist)
Pre-existing medical conditions such as uncontrolled cardiopulmonary disease, or metabolic diseases that could exacerbate with exercise
Are not English or Spanish speaking
Patients with secondary diagnosis (with the exception of basal cell carcinoma)
Participate in more than 60 minutes of moderate or vigorous structured exercise/week
Unable to travel to DFCI for necessary data collection
May not be able to comply with the safety monitoring requirements of the study in the opinion of the investigator.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT05327465) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Androgen Deprivation Therapy Treatment Options in Boston, MA

If you're searching for androgen deprivation therapy treatment options in Boston, MA, this clinical trial (NCT05327465) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced androgen deprivation therapy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all androgen deprivation therapy clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Boston, MA

See all rheumatoid arthritis clinical trials recruiting in Boston — not just this study.

Browse Rheumatoid Arthritis Trials in Boston

Browse More Trials by Condition

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA